About the Company
We do not have any company description for Aptorum Group Ltd at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Aptorum Group Ltd
Aptorum Group Limited Reports Financial Results and Business Update for ...
Financial Results for the Six Months Ended June 30, 2024 Aptorum Group reported a net loss of $2.7 million for the six months ended June 30, 2024 compared to $6.6 million for the same period in 2023.
Aptorum Group Limited Announces Receipt of Nasdaq Notification ...
Aptorum Group Limited has been granted a 180-calendar-day grace period, until 14 October 2025, to regain compliance with the continued listing requirements.
Aptorum Group Ltd Announces Entering into an Agreement and Plan of ...
Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet ...
Aptorum Group Limited Announces Pricing of $3.0 Million Registered ...
NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group" or the "Company"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical ...
Aptorum Group Limited Reports Financial Results and Business Update for ...
Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet ...
Aptorum Group Limited Regains Compliance with NASDAQ’s Minimum Bid ...
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," “Aptorum” or the "Company"), a clinical stage biopharmaceutical company dedicated to ...
Aptorum Group Limited Reports Financial Results and Business Update for ...
Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group” or the “Company”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and ...
Aptorum Group Limited Announces Pricing of $3.0 Million Registered ...
Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet ...
Aptorum Group Ltd - Ordinary Shares - Class A APM Overview
Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates ...
Aptorum Group Limited and DiamiR Biosciences Enter into ... - ABC27
Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet ...
Aptorum Group Limited Reports Financial Results and Business ... - Nasdaq
HONG KONG, Sept 1, 2020--- Aptorum Group Limited, a biopharmaceutical company focuses on the development of novel therapeutics to address global unmet medical needs, today provided a business ...
Aptorum Group Limited Reports 2020 Fiscal Year End Financial ... - Nasdaq
NEW YORK& LONDON& PARIS---- Aptorum Group Limited, a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology and infectious diseases, today announced ...
Similar Companies
| Company | Ticker | 90 Days Forecast | Market Cap. (USD M) | P/E | P/B |
|---|---|---|---|---|---|
| AUTOSCOPE TECHNOLOGIES CORP | AATC | Predict | 38.12 | 71.26 | 2.04 |
| Aptorum Group Ltd | APM | Predict | 40.03 | None | 1.27 |
| FARO TECHNOLOGIES INC | FARO | Predict | 841.72 | -35.44 | 3.24 |
| GEOSPACE TECHNOLOGIES CORP | GEOS | Predict | 208.11 | 22.41 | 1.55 |
| KNOW LABS, INC. | KNW | Predict | 55.92 | 2.07 | 7.98 |
| 908 Devices Inc. | MASS | Predict | 239.06 | -1.65 | 1.61 |
| Mirion Technologies, Inc. | MIR | Predict | 5181.47 | 518.15 | 3.54 |
| ONTO INNOVATION INC. | ONTO | Predict | 5263.33 | 26.33 | 2.68 |
| Owlet, Inc. | OWLT | Predict | 132.53 | -1.49 | -5.14 |
| Quantum-Si Inc | QSI | Predict | 0.00 | -3.02 | 0.00 |
| Quantum-Si Inc | QSIAW | Predict | 0.00 | None | 0.00 |
| ROCKWELL AUTOMATION, INC | ROK | Predict | 38746.10 | 39.94 | 11.19 |
| THERMO FISHER SCIENTIFIC INC. | TMO | Predict | 0.00 | 33.20 | 0.00 |
| TRIMBLE INC. | TRMB | Predict | 19573.67 | 71.14 | 3.61 |
| US NUCLEAR CORP. | UCLE | Predict | 1.14 | None | None |
Loading the latest forecasts...